Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Etomidate for Anesthesia Induction in Cardiac Patients Undergoing Non-Cardiac Surgery
ChiCTR2600119060Phase 4Not yet recruiting
- Sponsor
- Changzhou First People's Hospital
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in cardiac disease (4 arms), sponsored by Changzhou First People's Hospital. Primary endpoints: Stroke Volume, Cardiac Output and 4 more. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
cardiac disease
Beyond the preview
Go deeper on ChiCTR2600119060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119060.